Table 1.
Species | MIC (mg/L) | ||||
---|---|---|---|---|---|
|
|||||
Antifungal agent | Test method | Range | MIC 50 | A(%)* | |
C. albicans (5) | fluconazole | VITEK 2 | ≤ 1 | ||
CLSI | 0.12–0.25 | 0.12 | 100 | ||
AFST-EUCAST | 0.25–0.5 | 0.25 | 100 | ||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.015–0.25 | 0.015 | 100 | ||
AFST-EUCAST | 0.015–0.5 | 0.03 | 100 | ||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12–0.25 | 0.12 | 100 | ||
AFST-EUCAST | 0.25–0.5 | 0.25 | 100 | ||
amphotericin B | VITEK 2 | ≤ 0.25–1 | 0.5 | ||
CLSI | 0.12–0.5 | 0.25 | 100 | ||
AFST-EUCAST | 0.08–0.25 | 0.06 | 100 | ||
C. tropicalis (5) | fluconazole | VITEK 2 | ≤ 1 | ||
CLSI | 0.12–0.5 | 0.12 | 100 | ||
AFST-EUCAST | 0.25–1 | 0.25 | 100 | ||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.015–0.6 | 0.06 | 100 | ||
AFST-EUCAST | 0.03–0.12 | 0.03 | 100 | ||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12–2 | 0.12 | 100 | ||
AFST-EUCAST | 0.25–4 | 0.25 | 100 | ||
amphotericin B | VITEK 2 | ≤ 1 | |||
CLSI | 0.12–0.5 | 0.25 | 100 | ||
AFST-EUCAST | 0.25–1 | 0.12 | 100 | ||
C. glabrata (5) | fluconazole | VITEK 2 | 2 – ≥ 64 | 4 | |
CLSI | 1 – ≥ 64 | 1 | 50 | ||
AFST-EUCAST | 1 – ≥ 64 | 1 | 50 | ||
voriconazole | VITEK 2 | ≤ 0.12–1 | 0.12 | ||
CLSI | 0.06–4 | 0.12 | 100 | ||
AFST-EUCAST | 0.12–4 | 0.12 | 100 | ||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12–0.5 | 0.12 | 100 | ||
AFST-EUCAST | 0.25–0.5 | 0.25 | 100 | ||
amphotericin B | VITEK 2 | 0.5–1 | 0.5 | ||
CLSI | 0.5–1 | 0.5 | 100 | ||
AFST-EUCAST | 0.12–0.5 | 0.25 | 100 | ||
C. krusei (5) | fluconazole | VITEK 2 | 16–32 | 16 | |
CLSI | 16–32 | 32 | 100 | ||
AFST-EUCAST | 16–32 | 32 | 100 | ||
voriconazole | VITEK 2 | ≤ 0.12–0.25 | 0.25 | ||
CLSI | 0.12–0.5 | 0.5 | 100 | ||
AFST-EUCAST | 0.015–0.5 | 0.25 | 100 | ||
flucytosine | VITEK 2 | 8.0–16 | 16 | ||
CLSI | 4.0–16 | 8 | 100 | ||
AFST-EUCAST | 8 | 8 | 100 | ||
amphotericin B | VITEK 2 | 0.5–4 | 0.5 | ||
CLSI | 1 | 1 | 100 | ||
AFST-EUCAST | 0.5–2 | 0.5 | 100 | ||
C. parapsilosis (5) | fluconazole | VITEK 2 | ≤ 1–4 | ≤ 1 | |
CLSI | 0.12–0.5 | 80 | |||
AFST-EUCAST | 0.12–1 | 0.5 | 100 | ||
voriconazole | VITEK 2 | ≤ 0.12–0.25 | ≤ 0.12 | ||
CLSI | 0.12–0.5 | 0.15 | 100 | ||
AFST-EUCAST | 0.015–0.5 | 0.06 | 100 | ||
flucytosine | VITEK 2 | ≤ 1 | ≤ 1 | ||
CLSI | 0.12 | 0.12 | 100 | ||
AFST-EUCAST | 0.25 | 0.25 | 100 | ||
amphotericin B | VITEK 2 | ≤ 0.25–0.5 | ≤ 0.25 | ||
CLSI | 0.12–0.5 | 0.25 | 100 | ||
AFST-EUCAST | 0.06–0.5 | 0.12 | 100 | ||
C. lusitaniae (1) | fluconazole | VITEK 2 | ≤ 1 | ||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.25 | 100 | |||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.015 | 100 | |||
AFST-EUCAST | 0.03 | 100 | |||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.25 | 100 | |||
amphotericin B | VITEK 2 | ≥ 16 | 0 | ||
CLSI | 2 | 0 | |||
AFST-EUCAST | 2 | ||||
C. dubliniensis (1) | fluconazole | VITEK 2 | ≤ 1 | ||
CLSI | 0.25 | 100 | |||
AFST-EUCAST | 0.12 | 100 | |||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.015 | 100 | |||
AFST-EUCAST | 0.03 | 100 | |||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.25 | 100 | |||
amphotericin B | VITEK 2 | ≤ 0.25 | |||
CLSI | 0.25 | 100 | |||
AFST-EUCAST | 0.12 | 100 | |||
C. haemunolii (n=1) | fluconazole | VITEK 2 | ≥ 64 | ||
CLSI | 0.12 | 0 | |||
AFST-EUCAST | 0.12 | 0 | |||
voriconazole | VITEK 2 | 1 | |||
CLSI | 0.015 | 0 | |||
AFST-EUCAST | 0.03 | 0 | |||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.25 | 100 | |||
AFST-EUCAST | 0.5 | 100 | |||
amphotericin B | VITEK 2 | ≥ 16 | |||
CLSI | 8 | 100 | |||
AFST-EUCAST | 4 | 100 | |||
C. kefyr (n=1) | fluconazole | VITEK 2 | 2 | ||
CLSI | 0.5 | 100 | |||
AFST-EUCAST | 0.5 | 100 | |||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.03 | 100 | |||
AFST-EUCAST | 0.03 | 100 | |||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.12 | 100 | |||
amphotericin B | VITEK 2 | 2 | |||
CLSI | 0.25 | 0 | |||
AFST-EUCAST | 0.25 | 0 | |||
C. pelliculosa (n = 1) | fluconazole | VITEK 2 | 2 | ||
CLSI | 2 | 100 | |||
AFST-EUCAST | 2 | 100 | |||
voriconazole | VITEK 2 | ≤ 0.12 | |||
CLSI | 0.25 | 100 | |||
AFST-EUCAST | 0.25 | 100 | |||
flucytosine | VITEK 2 | ≤ 1 | |||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.25 | 100 | |||
amphotericin B | VITEK 2 | ≤ 0.25 | |||
CLSI | 0.12 | 100 | |||
AFST-EUCAST | 0.12 | 100 |
A, agreement (±2 Log 2 dilutions) between VITEK and broth microdilution method MICs.